Targeting PTEN-deficient T-cell acute lymphoblastic leukemia by exploiting a metabolic vulnerability downstream of mTOR
Principal Investigator: Alexander V. Neimark
Affiliation: Distinguished Professor, Department of Chemical and Biochemical Engineering, School of Engineering
Amount: $50,000
Research Sponsor: CINJ Blood Disorders Program